Education
About Us
Working with TipRanks
Follow Us
Rockwell Medical Technologies (RMTI)
NASDAQ:RMTI
RMTI Stock Chart & Stats
$1.04
-$0.08(-3.59%)
At close: 4:00 PM EST
$1.04
-$0.08(-3.59%)
Day’s Range― - ―
52-Week Range$0.78 - $5.15
Previous CloseN/A
Volume98.98K
Average Volume (3M)630.44K
Market Cap
$35.81M
Enterprise Value$24.68M
Total Cash (Recent Filing)$18.42M
Total Debt (Recent Filing)$14.01M
Price to Earnings (P/E)―
Beta1.91
Next Earnings
Nov 12, 2025EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding34,430,350
10 Day Avg. Volume356,193
30 Day Avg. Volume630,440
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.69
Enterprise Value/Revenue0.28
Enterprise Value/Gross Profit1.60
Enterprise Value/Ebitda20.02
Forecast
1Y Price Target
$4.00Price Target Upside284.62% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Long-term ContractsAt the midpoint of 2025, more than 80% of Rockwell Medical's customers are under long-term contracts.
Market PositionThe company is the largest supplier of liquid bicarbonate concentrates and the second-largest supplier of acid and dry bicarbonate concentrates for dialysis patients in the U.S.
Partnerships And AgreementsRockwell Medical recently entered into a product purchase agreement with Innovative Renal Care, one of the largest dialysis service providers in the United States.
Bears Say
Rockwell Med News
RMTI FAQ
What was Rockwell Medical Technologies’s price range in the past 12 months?
Rockwell Medical Technologies lowest stock price was $0.78 and its highest was $5.15 in the past 12 months.
What is Rockwell Medical Technologies’s market cap?
Rockwell Medical Technologies’s market cap is $35.81M.
When is Rockwell Medical Technologies’s upcoming earnings report date?
Rockwell Medical Technologies’s upcoming earnings report date is Nov 12, 2025 which is in 6 days.
How were Rockwell Medical Technologies’s earnings last quarter?
Rockwell Medical Technologies released its earnings results on Aug 14, 2025. The company reported -$0.05 earnings per share for the quarter, the consensus estimate of -$0.05 by $0.
Is Rockwell Medical Technologies overvalued?
According to Wall Street analysts Rockwell Medical Technologies’s price is currently Undervalued.
Does Rockwell Medical Technologies pay dividends?
Rockwell Medical Technologies does not currently pay dividends.
What is Rockwell Medical Technologies’s EPS estimate?
Rockwell Medical Technologies’s EPS estimate is -0.05.
How many shares outstanding does Rockwell Medical Technologies have?
Rockwell Medical Technologies has 34,430,350 shares outstanding.
What happened to Rockwell Medical Technologies’s price movement after its last earnings report?
Rockwell Medical Technologies reported an EPS of -$0.05 in its last earnings report, expectations of -$0.05. Following the earnings report the stock price went up 0.962%.
Which hedge fund is a major shareholder of Rockwell Medical Technologies?
Currently, no hedge funds are holding shares in RMTI
Rockwell Med Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (284.62% Upside)
$4.00 (284.62% Upside)
Blogger Sentiment
Bullish
RMTI Sentiment 100%
Sector Average ―
Sector Average ―
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-71.50%
12-Months-Change
Fundamentals
Return on Equity
-8.65%
Trailing 12-Months
Asset Growth
-0.76%
Trailing 12-Months
Company Description
Rockwell Medical Technologies
Rockwell Medical, Inc. (RMTI) is a biotechnology company focused on developing and commercializing innovative therapies for patients with end-stage renal disease (ESRD) and chronic kidney disease (CKD). The company operates primarily in the biotechnology and healthcare sectors, offering a range of products including dialysis solutions and iron replacement therapies, aimed at improving patient outcomes in renal care.
RMTI Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a company navigating a transition period with both challenges and strategic wins. While revenue and profitability have declined due to the loss of the largest customer, Rockwell Medical has improved its cash position, secured long-term contracts, and maintained operational efficiency. The positive steps towards stabilizing the business suggest potential for future growth, but the recent financial performance remains a concern.View all RMTI earnings summariesRMTI Stock 12 Month Forecast
Average Price Target
$4.00
▲(284.62% Upside)
Technical Analysis
Assertio Therapeutics
―
―
SCYNEXIS
―
Cumberland Pharmaceuticals
―
Kala Pharmaceuticals
―
Ownership Overview
15.33% Insiders
4.36% Mutual Funds
8.26% Other Institutional Investors
68.83% Public Companies and Individual Investors